Table 2.
In vitro T cell priming assay:
| Group |
IFN-γ(pg/ml) |
IL-2 (pg/ml) |
|---|---|---|
| Wild-type DCs + T cells | 48.0 ± 4.8 | 33.7 ± 5.7 |
| TCRδ−/− DCs + T cells | 43.3 ± 3.2 | 33.3 ± 5.8 |
| CD4+ T cells + OVA | 33.3 ± 8.4 | 33.3 ± 2.6 |
| Wild-type DCs + OVA + CD4+ T cells | 31,242 ± 1623 | 18,953 ± 759 |
| TCRδ−/− DCs + OVA + CD4+ T cells | 21,640 ± 835** | 16,543 ± 392* |
Purified naïve CD4+ T cells from OT II transgenic mice were co-cultured with DCs from WNV-infected wild-type or TCRδ−/ − mice in the presence or absence of OVA 323–339. At 24 h post coculture, supernatant was harvested and measured for cytokine production using mouse Th1/Th2 cytokine kit. Data are presented as means ± SEM, n = 3.
P < 0.05 or
P < 0.01 for wild-type vs. TCRδ−/ −.
P values were calculated with a non-paired Student’st test. Data shown were representative of two independent experiments.